Dr. Wandell is an Entrepreneur in Residence (EIR) at Rice University's Houston Area Translational Research Consortium (HATRC), a "think tank" with an outcome-based mission: to bridge the gap between basic research and the health care marketplace. As biomedical executive and clinical pharmacologist, Dr. Wandell has a track record of applying sound judgment grounded in high ethical standards to create regulatory strategies delivering novel medic

Natalie Wright Curley, J.D. is a registered patent attorney with over 17 years of experience in intellectual property and licensing. She specializes in assisting new and small biotech start ups with university transactions, including licensing, sponsored research and faculty consulting agreements, as well as IP and business strategy. Natalie specialties intellectual property law, university licensing and contracts, faculty consulting agreements,

Dmitri Lapotko (Rice University): more than 20 years of experience in biomedical nanophotonics. He invented plasmonic nanobubbles and the diagnostic and therapeutic cell level technologies [4,5]. He has more than 50 publications on nanophotonics and nanobubbles and a state of the art lab for in vitro and in vivo photonic research and engineering.

Dr. David Sullivan (Johns Hopkins Malaria Research Institute) has 20 years of experience in malaria research [1] with his laboratory now with more than a dozen researchers working on all aspects of the malaria lifecycle in relationship to biology, pathogenesis, diagnostics, drugs, immunology, vaccines and epidemiology. He has more than 30 publications on hemozoin and/or malaria diagnostics.